Cite
HARVARD Citation
Davis, J. et al. (2018). Evaluation of Potential Disease‐Mediated Drug–Drug Interaction in Patients With Moderate‐to‐Severe Atopic Dermatitis Receiving Dupilumab. Clinical pharmacology & therapeutics. 104 (6), pp. 1146-1154. [Online].